Influence of Type 1 Diabetes (T1DM) Treatment Type on Mental Workload
- Conditions
- TreatmentType 1 Diabetes
- Registration Number
- NCT06165159
- Lead Sponsor
- University Hospital, Angers
- Brief Summary
Influence of the type of treatment for type 1 diabetes (pump versus multiple injections versus closed loop) on the treatment burden of children and adolescents and their parents.
- Detailed Description
"The guidelines for the treatment of children and adolescents with type 1 diabetes emphasise an individualised approach to the child and provide target values (time in range, glycaemia and coefficient of variation). These recommendations aim to prevent long-term complications. It is rarely possible to achieve and maintain this level of control over the long term. Achieving these recommendations requires a great deal of investment from children and their families, which can significantly increase their psychological workload and reduce their quality of life.
The main aim of this study was to assess burden of treatment according to the treatment type (pump versus multiple injections versus closed loop) on a large scale."
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 800
- Children over the age of 8 whose type 1 diabetes has been diagnosed for at least 6 months
- Parents or people involved in the day-to-day life of children with type 1 diabetes who have been diagnosed for at least 6 months
- Parents not involved in managing their child's type 1 diabetes (child in care)
- Have already completed the questionnaire (one questionnaire completed per child and their parents or family caregivers)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome corresponds to the score obtained after completing the study questionnaire. The questionnaire is completed at the participation agreement. 1 day The primary outcome is the treatment burden according to the treatment modality (semi-closed loop versus insulin pump versus multi-injection) assessed using a specific questionnaire
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Emmanuelle LABARRE
🇫🇷Angers, France